EMERYVILLE, Calif., Oct. 31, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the Benchmark Company, LLC Micro Cap Discovery One-on-One Conference to be held December 1, 2016, at the Palmer House Hilton Hotel in Chicago. Due to the format of the event, no webcast will be available.
Management will be available for one-on-one meetings with institutional investors throughout the conference. Interested investors should contact their Benchmark Company, LLC, representative to schedule a meeting.
Amyris is scheduling an investor day in New York to provide a detailed update regarding recently announced collaborations and to provide an update to the progress on its forward outlook.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are registered trademarks of Amyris, Inc.
Contact: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 [email protected] [email protected]


Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 



